Glycated Haemoglobin (HbA1C) in Cardiac Surgery: A Narrative Review
Journal of Clinical Medicine · 24.12.2024 · 14 (1) · 23
DOI: 10.3390/jcm14010023 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Journal of Clinical Medicine, online erschienen am 24.12.2024. Verfasst von Suvitesh Luthra und 4 weiteren Autor:innen. Beteiligte Einrichtung: Wessex Cardiothoracic Centre, Division of Cardiac Surgery, University Hospital Southampton NHS Foundation Trust, Southampton SO16 6YD, UK. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 49 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Perioperative dysglycaemia in cardiac surgery is associated with poor outcomes. Glycaemic variability rather than glucose levels is a predictor of the length of an ICU stay, a rise in creatinine and acute kidney injury after cardiac surgery. Glycated haemoglobin (HbA1C) values correspond closely to average blood glucose levels and cut-off values can be used to define a diabetic and pre-diabetic status. These have been correlated with perioperative events.
Methods
In this narrative review, MEDLINE (via PubMed) and the Cochrane Library were used to search for the effects of different preoperative HbA1C levels on the postoperative outcomes after cardiac surgery. HbA1C values correspond closely with average blood glucose levels and cut-off values can be used to define a diabetic and pre-diabetic status; these have been correlated with perioperative events. This narrative review discusses the role of HbA1C in cardiac surgery.
Discussion
The scientific data show controversial results: some systematic reviews and randomised control trials demonstrated that a high level of HbA1C seems to be an indicator for postoperative complications in cardiac surgery; other studies dissented and reported that mortality and morbidity cannot be directly attributed to HbA1c levels.
Conclusions
The scientific community seems to be in general agreement that high levels of HbA1C are prognostic markers of adverse outcomes post cardiac surgery, but it has also been proved that there could be multiple underlying factors contributing to them.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Wessex Cardiothoracic Centre, Division of Cardiac Surgery, University Hospital Southampton NHS Foundation Trust, Southampton SO16 6YD, UK.
- Academic Unit of Human Development and Health, Faculty of Medicine, University of Southampton, Southampton SO17 1BJ, UK.
ORCID-Profile: Suvitesh Luthra, Laura Viola
Zitieren
APA
Luthra, S., Viola, L., Navaratnarajah, M., Thirukumaran, D., & Velissaris, T. (2024). Glycated Haemoglobin (HbA1C) in Cardiac Surgery: A Narrative Review. Journal of Clinical Medicine, 14(1), 23. https://doi.org/10.3390/jcm14010023
Vancouver
Luthra S, Viola L, Navaratnarajah M, Thirukumaran D, Velissaris T. Glycated Haemoglobin (HbA1C) in Cardiac Surgery: A Narrative Review. Journal of Clinical Medicine. 2024;14(1):23. doi:10.3390/jcm14010023
BibTeX
@article{Luthra2024,
author = {Luthra, Suvitesh and Viola, Laura and Navaratnarajah, Manoraj and Thirukumaran, David and Velissaris, Theodore},
title = {Glycated Haemoglobin (HbA1C) in Cardiac Surgery: A Narrative Review},
journal = {Journal of Clinical Medicine},
year = {2024},
volume = {14},
number = {1},
pages = {23},
doi = {10.3390/jcm14010023}
}
EUVIMED